300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Financial Services
Construction
Oil and Gas
Mobile
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Real Estate
Mobile Apps
Finance
Manufacturing
FinTech
Social Media
Franchise
Sporting Goods
Internet
Mobile Advertising
Android
Music
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Art
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Armenia
Colombia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Seychelles
Moldova
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Hackensack Meridian Health, VC Fund

Hackensack Meridian Health

VC Fund

Edison, United States

Hackensack Meridian Health is a not-for-profit health care organization that offers medical services, research, and life care. They manage ambulatory care centers, surgery centers, home health services, long-term care and assisted living communities, ambulance services, lifesaving air medical transportation, fitness and wellness centers,rehabilitation centers, and urgent care centers.

Total investments:
6
Last investment:
Lead investor:
17%

Last updated:

Industries Hackensack Meridian Health invests in

Health CareBiotechnologyMedicalSoftwareInformation Technology

Stages Hackensack Meridian Health invests in

Series ASeries CPrivate EquityCorporate RoundVenture - Series Unknown

Countries Hackensack Meridian Health invests in

United States

Contacts

NameEmailPhoneSocials
Andrew Pecora Andrew Pecora
Donna Snider Donna Snider
John K. Lloyd John K. Lloyd
Joseph Lemaire Joseph Lemaire
Kenneth Sable Kenneth Sable
See all 7 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Health Care 6 (100%)
  • Biotechnology 3 (50%)
  • Medical 2 (33%)
  • Software 2 (33%)
  • Information Technology 2 (33%)
See all 16 industries →

Stage

  • Series A 2 (33%)
  • Series C 1 (17%)
  • Private Equity 1 (17%)
  • Corporate Round 1 (17%)
  • Venture - Series Unknown 1 (17%)

Team

NameTitleInvestmentsLinksEmail
Andrew Pecora
Andrew Pecora Senior Scientist, Institute for Biomedical Research
Senior Scientist, Institute for Biomedical Research Total investments: 0
Find email
Donna Snider
Donna Snider Chief Investment Officer
Chief Investment Officer Total investments: 0
Find email
John K. Lloyd
John K. Lloyd Co CEO
Co CEO Total investments: 0
Find email
Joseph Lemaire
Joseph Lemaire President
President Total investments: 0
Find email
Kenneth Sable
Kenneth Sable President of Acute Care Hospital Division
President of Acute Care Hospital Division Total investments: 0 Find email
See all 7 team members →

Investments

CompanyDescriptionRoundLinks
Canary Speech Canary Speech
Canary Speech is a technology company that uses AI-driven vocal digital biomarkers for conversational speech virtual health monitoring. The company's vocal biomarker technology enables voice to be used as a vital sign, ushering in a new era of machine learning in healthcare. Using only 20 seconds of conversational speech, its patented vocalbiomarker technology models acoustic and linguistic features and returns analysis. Canary detects stress, mood, and energy levels before traditional clinical screening and visible symptoms, allowing clinicians, payers, and patients to address conditions more proactively.Canary's technology reduces readmissions, prevents hospitalizations, and provides a head start on wellness for patients and providers. Its current research simulates respiratory conditions, dementia and Alzheimer's disease, and clinical deterioration, with broad practical implications for simulating other disease states. $13M / Series A / Jun 11, 2024
FluidForm Bio FluidForm Bio
FluidForm Bio™ is creating living human tissue for better treatment of disease. Our patented FRESH™ technology is a revolutionary platform designed to build tissue using cells, proteins, and nothing else. Through partnerships with top life science companies, our technology has been validated to produce the highest quality tissue in a variety ofapplications.  We deliver human tissue that is indistinguishable from the real thing by integrating breakthrough innovations in 3D printing, computational and synthetic biology, AI, and advanced materials science. Our living tissue will offer therapies to countless patients who deserve better treatment options.  FluidForm Bio™was founded in 2018 on the belief that the world needs transformational technologies led by creative and passionate experts that help people lead better lives. Headquartered in Waltham, MA. Venture - Series Unknown / Jan 11, 2022
Med-Metrix Med-Metrix
Med-Metrix provides Performance Management and Revenue Cycle solutions to the healthcare industry. Designed specifically to improve clients' margins and productivity, their offerings leverage their proprietary FLOWtechnology platform ® of graphic-rich reporting and automated workflow coupled with advisory and outsource services as needed. Private Equity / Sep 27, 2021
EpiBone EpiBone
EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like living bone graft. EpiBone is strategically positioned to provide a superiorbone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year. Corporate Round / May 19, 2020
Pillo Health Pillo Health
Pillo Health provides HIPAA compliant tools for caregivers and health organizations to deliver better care to loved ones and patients living at home. The company's care delivery platform is centered on an intelligent healthcare assistant called Pillo. In addition to managing medications, Pillo can provide patients at home with health andwellness information, can proactively deliver digital care plans into the home, and can connect the home to care teams via smart notifications and video calling. The company also offers an SDK for partner organizations to create their own unique skills for Pillo by leveraging the company's proprietary in home voice first device. $11M / Series A / May 29, 2019
COTA Healthcare COTA Healthcare
COTA was founded in 2011 by doctors, engineers, and data scientists to create clarity from fragmented and often-inaccessible real world data. By using proprietary technology, advanced analytics and deep expertise to organize complex data, COTA provides a comprehensive picture of cancer that can be used to advance care and research. $40M / Series C / Feb 21, 2018

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Financial Services
Construction
Oil and Gas
Mobile
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Real Estate
Mobile Apps
Finance
Manufacturing
FinTech
Social Media
Franchise
Sporting Goods
Internet
Mobile Advertising
Android
Music
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Art
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Armenia
Colombia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Seychelles
Moldova
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Hackensack Meridian Health invest in?

Hackensack Meridian Health invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Series C stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Hackensack Meridian Health?

Public channels for Hackensack Meridian Health include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Hackensack Meridian Health?

The team at Hackensack Meridian Health includes Andrew Pecora (Senior Scientist, Institute for Biomedical Research), Donna Snider (Chief Investment Officer) and John K. Lloyd (Co CEO), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Hackensack Meridian Health Hackensack Meridian Health Find emails